Alcohol-related Liver Disease
📧 Sign up to get email alerts when something new happens for Alcohol-related Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
ClinicalTrials.gov update announcing an actively recruiting study of chronic liver diseases associated with alcohol use and metabolic syndro…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease [NA]
This clinical trial update notes the implementation of a mobile-based program to support alcohol cessation in people with alcohol use disord…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: CM for Patients With ALD After Liver Transplant [NA]
This clinical trial update reports on a study using contingency management for patients with alcohol-related liver disease after liver trans…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: FibroScan-Reproducibility and Repeatability Study [NA]
A completed clinical trial assessing the reproducibility and repeatability of FibroScan measurements in patients with non-alcoholic fatty li…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Peer Support for Liver Transplant Recipients With History of ALD [NA]
A Johns Hopkins University trial is investigating peer support for liver transplant recipients with a history of alcohol-related liver disea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease [Phase 2]
Phase 2 trial evaluating NNC0194-0499, cagrilintide, and semaglutide, alone or in combinations, for liver damage and alcohol use in alcohol-…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients [NA]
A Henry Ford Health System-sponsored clinical trial is currently recruiting to enhance engagement in alcohol treatment among patients with a…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: LGG Supplementation in Patients With AUD and ALD [Phase 2]
Phase 2 clinical trial evaluating LGG probiotic supplementation in adults with alcohol use disorder and alcohol-associated liver disease, cu…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: Digoxin In Treatment of Alcohol Associated Hepatitis [Phase 2]
Phase 2 trial of digoxin in Acute Alcoholic Hepatitis was terminated; no efficacy or safety results are provided in this update.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use [NA]
A clinical trial update examining how COVID-19 affects outcomes, care, and alcohol use among patients with alcohol-related liver disease and…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests
This clinical trial aims to predict recompensation in patients with decompensated cirrhosis using spleen stiffness measurements and simple b…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
A HepQuant, LLC trial is evaluating the HepQuant DuO Test as a biomarker for alcohol-related liver disease, including alcoholic hepatitis, a…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial is exploring fecal microbiota transplantation for alcohol-related liver disease and cirrhosis and is currently re…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)
This clinical trial update describes the LOVE study's long-term follow-up to determine outcomes in MASLD/MASH and related steatotic liver di…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.
Clinical trial evaluating the LIVERFASt diagnostic test for diagnosing liver fibrosis and steatosis, using MR elastography as a reference st…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients with Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement [NA]
A clinical trial update describing a study that assesses cardiac function using MRI and echocardiography in patients with alcohol-related li…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Metabolic Changes in Healthy Subjects with Acute Binge Drink [Phase 1]
Phase 1 clinical trial investigating metabolic changes in healthy subjects following acute binge drinking. The study has been completed.
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Genetic Polymorphisms Associated With the Risk of Pancreatitis in Patients With Alcohol Related Cirrhosis.
A clinical trial update describing an investigation into genetic polymorphisms associated with pancreatitis risk in patients with alcohol-re…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Risk and Protective Factors for Relapse to Alcohol Use in Patients With Liver Disease Undergoing Liver Transplantation
This clinical trial aims to identify risk and protective factors related to relapse to alcohol use in patients with alcohol-related liver di…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Investigating Myosteatosis in Steatotic Liver Diseases
Clinical trial update on investigating myosteatosis in steatotic liver diseases. Enrollment is by invitation.
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to Reduce Its Burden. [NA]
This clinical trial update describes a study investigating drivers of late diagnosis of alcohol-related diseases, including metabolic dysfun…
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) Signaling [NA]
A completed clinical trial evaluated how heavy alcohol consumption affects Farnesoid X Receptor (FXR) signaling.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: Acamprosate Safe to Use in Individuals With Liver Disease. [Phase 2]
A Phase 2 trial suggests acamprosate is safe to use in individuals with liver disease for alcohol-related liver disease.
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: Online Education to Inform the Elderly About Age-related Alcohol Risks [Phase 2]
Phase 2 clinical trial update assessing online education to inform elderly individuals about age-related alcohol risks and drug–food interac…